Qiming U.S. Healthcare Fund II, L.P. files SEC Form 4 disclosures for Icosavax, Inc.. They have made 2 open-market trades across 2 companies since 2021, most recently 2021-08-02.
CIK 0001765710
2 open-market purchases totalling $8.3M since 2021, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.